You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)

 

Online download statistics by month:

Online download statistics by month: February 2021 to March 2024

AbstractFullPdf
Feb 202124724083
Mar 2021545318
Apr 2021474515
May 2021363320
Jun 2021343011
Jul 2021424210
Aug 2021282813
Sep 2021414023
Oct 2021525232
Nov 2021161716
Dec 2021222013
Jan 202225269
Feb 2022374019
Mar 2022423718
Apr 2022323118
May 2022737022
Jun 2022424110
Jul 202222233
Aug 2022353711
Sep 2022545414
Oct 2022636515
Nov 202241398
Dec 202249459
Jan 2023485124
Feb 2023737016
Mar 202348496
Apr 2023555210
May 2023323210
Jun 202330286
Jul 202331318
Aug 2023444314
Sep 202330296
Oct 202343428
Nov 2023727214
Dec 202332285
Jan 2024242420
Feb 2024615541
Mar 2024585934
Total18151773632